Atossa Genetics (ATOS)
0.4884
-0.03 -5.71%
NASDAQ
Sep 22, 20:00
Delayed 2m
USD
View All Key Stats
ATOS Key Stats
| Income Statement | |
| Revenue (TTM) | -- |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -1.74 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -6.264M |
| Profitability | |
| Gross Profit Margin (Quarterly) | -- |
| Profit Margin (Quarterly) | -- |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | 0.00 |
| Price and Valuation | |
| Market Cap | 5.715M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | -- |
| PE Ratio (TTM) | -- |
| Price to Book Value | 2.038 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | -- |
| Free Cash Flow (Quarterly) | -1.349M |
| Return on Equity (TTM) | -- |
View All ATOS News
ATOS News
-
WireHeadlineTime (ET)
-
SA Breaking News09/22 16:32
-
Yahoo09/19 08:05
-
MT Newswires09/14 14:09
-
SA Breaking News09/14 13:31
-
Globe Newswire09/14 13:00
-
Yahoo09/14 13:00
-
Yahoo09/13 08:10
-
Globe Newswire09/11 08:15
-
Yahoo09/11 08:15
-
Yahoo08/31 09:20
ATOS Fundamentals
Income Statement View Statement
ATOS Ratings
Advertisement
ATOS One Page Reports
- One Page Report Download
ATOS Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Target Price | |
| Price | 0.4884 |
| Price Target | Upgrade |
Edit
Profile
- URL: http://www.atossagenetics.com
- Investor Relations URL: http://ir.atossagenetics.com/
- HQ State/Province: Washington
- Sector: Healthcare
- Industry: Diagnostics & Research
- Next Earnings Release: N/A
- Last Earnings Release: Aug. 15, 2016
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Atossa Genetics Inc is a clinical-stage pharmaceutical company engaged in the development of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions.
ATOS Comparables
EditATOS Excel Add-In Codes
- Name: =YCI("ATOS","name")
- Description: =YCI("ATOS","description")
- Sector: =YCI("ATOS","sector")
- Industry: =YCI("ATOS","industry")
- Est. Current Fiscal Year End: =YCI("ATOS","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other ATOS Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- ATOS Tweets Stocktwits
Advertisement
